Distribution of Pathogenicity Island Markers and H-Antigen Types of Escherichia coli O25b/ST131 Isolates from Patients with Urinary Tract Infection in Iran

Microb Drug Resist. 2021 Mar;27(3):369-382. doi: 10.1089/mdr.2019.0485. Epub 2020 Jul 21.

Abstract

Escherichia coli serogroup O25b-sequence type 131 (E. coli O25b/ST131) is known as a multidrug-resistant organism with high virulence potential and has received attention internationally. We aim to investigate the prevalence of O25b/ST131 and the distribution of blaCTX-M-15, pathogenicity island (PAI) markers, phylogenetic groups, and H-antigen typing in the E. coli O25b/ST131 isolated from patients with urinary tract infection (UTI) in Tehran, the capital of Iran. Seventy (26.9%) E. coli isolates were identified as O25b/ST131. There was also a significant difference in the prevalence of virulence genes, including papA, sfa, sat, cnf1, iutA, kpMII, traT, and usp, in the O25b/ST131 isolates rather than non-O25b/ST131 ones (p ≤ 0.05). Furthermore, 78% of the O25b/ST131 isolates carried four to seven PAIs, while 71% of non-O25b/ST131 isolates carried two to four PAI markers (p ≤ 0.05). Our study showed that in addition to H4, other H-antigens may play a role in the O25b/ST131 virulence potential. Besides, a significant association was found between the history of previous UTIs and infection among the O25b/ST131 clone isolates. Pulsed-field gel electrophoresis revealed circulating of O25b:H4-ST131/PST43 clone in both hospital and community. Approximately one in every three uropathogenic E. coli isolates was the O25b/ST131 clone, representing a significant public health threat. Practical investigation on O25b/ST131 can be helpful in better understanding of ST131 evolution and controlling UTI in hospitals.

Keywords: extended-spectrum beta-lactamases; flagella; pathogenicity islands; phylogenetic; uropathogenic Escherichia coli.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Antigens, Bacterial / genetics*
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Genomic Islands / genetics*
  • Hospitals, University
  • Humans
  • Iran / epidemiology
  • Molecular Epidemiology
  • Multilocus Sequence Typing
  • Urinary Tract Infections / microbiology*
  • Uropathogenic Escherichia coli / genetics*
  • Virulence

Substances

  • Anti-Bacterial Agents
  • Antigens, Bacterial